Small Study Suggests Lasting Benefits from Aldosterone Synthase Inhibition
A Queen Mary-led follow-up involving 14 people reports sustained hormone and blood-pressure improvements for up to two years after aldosterone-targeting treatment stopped. The finding is promising, but remains preliminary.
6 min read ↗